Exosomes: roles and therapeutic potential in osteoarthritis

Abstract

Exosomes participate in many physiological and pathological processes by regulating cell–cell communication, which are involved in numerous diseases, including osteoarthritis (OA). Exosomes are detectable in the human articular cavity and were observed to change with OA progression. Several joint cells, including chondrocytes, synovial fibroblasts, osteoblasts, and tenocytes, can produce and secrete exosomes that influence the biological effects of targeted cells. In addition, exosomes from stem cells can protect the OA joint from damage by promoting cartilage repair, inhibiting synovitis, and mediating subchondral bone remodeling. This review summarizes the roles and therapeutic potential of exosomes in OA and discusses the perspectives and challenges related to exosome-based treatment for OA patients in the future.

References

[1] GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392:1923-1994

[2] Hawker GA, White D, Skou ST. Non-pharmacological management of osteoarthritis. Osteoarthr. Cartil., 2017, 25:S4

[3] Bannuru RR et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr. Cartil., 2019, 27:1578-1589

[4] Kloppenburg M, Berenbaum F. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthr. Cartil., 2020, 28:242-248

[5] Dieppe P, Lim K, Lohmander S. Who should have knee joint replacement surgery for osteoarthritis? Int J. Rheum. Dis., 2011, 14:175-180

[6] Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum., 2012, 64:1697-1707

[7] Chen D et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res., 2017, 5:1-13

[8] Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr. Opin. Rheumatol., 2018, 30:160-167

[9] Burr DB. The importance of subchondral bone in osteoarthrosis. Curr. Opin. Rheumatol., 1998, 10:256-262

[10] de Lange-Brokaar BJ et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthr. Cartil., 2012, 20:1484-1499

[11] Glyn-Jones S et al. Osteoarthritis. Lancet, 2015, 386:376-387

[12] Lin C et al. Activation of mTORC1 in subchondral bone preosteoblasts promotes osteoarthritis by stimulating bone sclerosis and secretion of CXCL12. Bone Res., 2019, 7:5

[13] Zhen G et al. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med., 2013, 19:704-712

[14] Sharma AR, Jagga S, Lee SS, Nam JS. Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis. Int. J. Mol. Sci., 2013, 14:19805-19830

[15] Mathiessen A, Conaghan PG. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res. Ther., 2017, 19:18

[16] Kuang L et al. FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice. Ann. Rheum. Dis., 2020, 79:112-122

[17] Clockaerts S et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthr. Cartil., 2010, 18:876-882

[18] Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol., 2017, 27:172-188.

[19] Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol., 2006, Chapter 3:Unit 3:22

[20] Trams EG, Lauter CJ, Salem N Jr., Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta, 1981, 645:63-70

[21] Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol., 1983, 97:329-339

[22] Pan BT, Teng K, Wu C, Adam M, Johnstone RM. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol., 1985, 101:942-948

[23] Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem., 1987, 262:9412-9420

[24] Raposo G et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med., 1996, 183:1161-1172

[25] Wolfers J et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med., 2001, 7:297-303

[26] Zitvogel L et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med., 1998, 4:594-600

[27] Valadi H et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 2007, 9:654-659

[28] Mathieu M, Martinjaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol., 2019, 21:9-17

[29] Pluchino S, Smith JA. Explicating exosomes: reclassifying the rising stars of intercellular communication. Cell, 2019, 177:225-227

[30] Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol., 2002, 2:569-579

[31] Batista BS, Eng WS, Pilobello KT, Hendricks-Muñoz KD, Mahal LK. Identification of a conserved glycan signature for microvesicles. J. Proteome Res., 2011, 10:4624-4633

[32] Heijnen, H. F. G., Schiel, A. E., Fijnheer, R., Geuze, H. J. & Sixma, J. J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791–3799 (1999).

[33] Hanson, P. I., Shim, S. & Merrill, S. A. Cell biology of the ESCRT machinery. Curr. Opin. Cell Biol. 21, 568–574 (2009).

[34] Hurley JH, Odorizzi G. Get on the exosome bus with ALIX. Nat. Cell Biol., 2012, 14:654-655

[35] Mayers, J. R. & Audhya, A. Vesicle formation within endosomes: an ESCRT marks the spot. Commun. Integr. Biol. 5, 50–56 (2012).

[36] Nabhan JF, Hu R, Oh RS, Cohen SN. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc. Natl. Acad. Sci. USA, 2012, 109:4146-4151

[37] Henne WM, Stenmark H, Emr D. Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb. Perspect. Biol., 2013, 5:a016766

[38] Raiborg, C. & Stenmark, H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458, 445–452 (2009).

[39] Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).

[40] Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244–1247 (2008).

[41] Yang D et al. Progress, opportunity, and perspective on exosome isolation—efforts for efficient exosome-based theranostics. Theranostics, 2020, 10:3684-3707

[42] Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics, 2017, 7:789-804

[43] Gurunathan, S., Kang, M. H., Jeyaraj, M., Qasim, M. & Kim, J. H. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 8, 307 (2019).

[44] Zarovni N et al. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods, 2015, 87:46-58

[45] Jeppesen DK et al. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J. Extracell. Vesicles, 2014, 3:25011

[46] Cheruvanky A et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am. J. Physiol. Ren. Physiol., 2007, 292:F1657-F1661

[47] Heinemann ML et al. Benchtop isolation and characterization of functional exosomes by sequential filtration. J. Chromatogr. A., 2014, 1371:125-135

[48] Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J. Control Release, 2015, 219:396-405

[49] Yamamoto KR, Alberts B, Benzinger R, Lawhorne LW, Treiber G. Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification. Virology, 1970, 40:734-744

[50] Lewis G, Metcalf TG. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Appl. Environ. Microbiol., 1988, 54:1983-1988

[51] Adams A. Concentration of epstein-barr virus from cell culture fluids with polyethylene glycol. J. Gen. Virol., 1973, 20:391-394

[52] Wang Z et al. Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip., 2013, 13:2879-2882

[53] Lee K, Shao H, Weissleder R, Lee H. Acoustic purification of extracellular microvesicles. ACS Nano., 2015, 9:2321-2327

[54] Davies RT et al. Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip., 2012, 12:5202-5210

[55] Liga A, Vliegenthart ADB, Oosthuyzen W, Dear JW, Kersaudy-Kerhoas M. Exosome isolation: a microfluidic road-map. Lab Chip., 2015, 15:2388-2394

[56] Wunsch BH et al. Nanoscale lateral displacement arrays for the separation of exosomes and colloids down to 20 nm. Nat. Nanotechnol., 2016, 11:936-940

[57] Lässer C., Eldh M., Lötvall J. Isolation and characterization of RNA-containing exosomes. J. Vis. Exp. 59, e3037 (2012).

[58] Wu, Y., Deng, W. & Klinke, D. J. 2nd. Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst 140, 6631–6642 (2015).

[59] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science, 2020, 367

[60] Thery C et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles, 2018, 7:1535750

[61] Escola JM et al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem., 1998, 273:20121-20127

[62] Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol., 2002, 2:569-579

[63] Melo SA et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature, 2015, 523:177-182

[64] Ruivo CF, Adem B, Silva ML, Melo SA. The biology of cancer exosomes: insights and new perspectives. Cancer Res., 2017, 77:6480-6488

[65] Danzer KM et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener., 2012, 7:42

[66] Sardar Sinha M et al. Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol., 2018, 136:41-56

[67] Ding X et al. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget, 2015, 6:24178-24191

[68] Yang C, Robbins PD. Immunosuppressive exosomes: a new approach for treating arthritis. Int. J. Rheumatol., 2012, 2012:573528

[69] Kim SH et al. Exosomes Derived from IL-10-Treated Dendritic Cells Can Suppress Inflammation and Collagen-Induced. Arthritis, 2005, 174:6440-6448

[70] Michael A et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis., 2010, 16:34-38

[71] Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen. Med., 2011, 6:481-492

[72] Bellin G et al. Exosome in cardiovascular diseases: a complex world full of hope. Cells, 2019, 8:166

[73] Gao M et al. Exosomes-the enigmatic regulators of bone homeostasis. Bone Res., 2018, 6:36

[74] Rodan GA. Bone homeostasis. Proc. Natl Acad. Sci. USA., 1998, 95:13361-13362

[75] Ge M, Ke R, Cai T, Yang J, Mu X. Identification and proteomic analysis of osteoblast-derived exosomes. Biochem. Biophys. Res. Commun., 2015, 467:27-32

[76] Cui Y, Luan J, Li H, Zhou X, Han J. Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression. FEBS Lett., 2016, 590:185-192

[77] Li D et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat. Commun., 2016, 7

[78] Sun W et al. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity. Cell Discov., 2016, 2:16015

[79] Yang J-X, Xie P, Li Y-S, Wen T, Yang X-C. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2. Cell. Signal., 2019, 70:109504

[80] Qin Y et al. Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication. J. Biol. Chem., 2017, 292:11021-11033

[81] Kuang MJ et al. Exosomes derived from Wharton’s jelly of human umbilical cord mesenchymal stem cells reduce osteocyte apoptosis in glucocorticoid-induced osteonecrosis of the femoral head in rats via the miR-21-PTEN-AKT signalling pathway. Int. J. Biol. Sci., 2019, 15:1861-1871

[82] Ren L et al. Adipose mesenchymal stem cell-derived exosomes ameliorate hypoxia/serum deprivation-induced osteocyte apoptosis and osteocyte-mediated osteoclastogenesis in vitro. Biochem. Biophys. Res. Commun., 2019, 508:138-144.

[83] Qi X et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int. J. Biol. Sci., 2016, 12:836-849

[84] Zhang Y et al. Transfer RNA-derived fragments as potential exosome tRNA-derived fragment biomarkers for osteoporosis. Int. J. Rheum. Dis., 2018, 21:1659-1669

[85] Jiang LB, Tian L, Zhang CG. Bone marrow stem cells-derived exosomes extracted from osteoporosis patients inhibit osteogenesis via microRNA-21/SMAD7. Eur. Rev. Med. Pharmacol. Sci., 2018, 22:6221-6229

[86] Zhao P, Xiao L, Peng J, Qian YQ, Huang CC. Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway. Eur. Rev. Med. Pharmacol. Sci., 2018, 22:3962-3970

[87] Yang X, Yang J, Lei P, Wen T. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging, 2019, 11:8777-8791

[88] Yang BC et al. Human umbilical cord mesenchymal stem cell-derived exosomes act via the miR-1263/Mob1/Hippo signaling pathway to prevent apoptosis in disuse osteoporosis. Biochem. Biophys. Res. Commun., 2020, 524:883-889

[89] Liu X et al. Exosomes secreted from human-induced pluripotent stem cell-derived mesenchymal stem cells prevent osteonecrosis of the femoral head by promoting angiogenesis. Int. J. Biol. Sci., 2017, 13:232-244

[90] Li Y et al. Mesenchymal stem cells-derived exosomes: a possible therapeutic strategy for osteoporosis. Curr. Stem Cell Res. Ther., 2018, 13:362-368

[91] Hao ZC et al. Stem cell-derived exosomes: a promising strategy for fracture healing. Cell Prolif., 2017, 50

[92] Liu W et al. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomaterialia., 2020, 103:196-212

[93] Furuta T et al. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl. Med., 2016, 5:1620-1630

[94] Zhang L et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis in a rat model of nonunion. Stem Cell Res. Ther., 2020, 11:38

[95] Zhang Y et al. Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF-1alpha-mediated promotion of angiogenesis in a rat model of stabilized fracture. Cell Prolif., 2019, 52

[96] Domenis R et al. Characterization of the proinflammatory profile of synovial fluid-derived exosomes of patients with osteoarthritis. Mediators Inflamm., 2017, 2017:4814987

[97] Skriner K, Adolph K, Jungblut PR, Burmester GR. Association of citrullinated proteins with synovial exosomes. Arthritis Rheumatism., 2006, 54:3809-3814

[98] Gao K et al. Association between cytokines and exosomes in synovial fluid of individuals with knee osteoarthritis. Mod. Rheumatol., 2019, 2019:1-7

[99] Kolhe R et al. Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci. Rep., 2017, 7

[100] Headland SE et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci. Transl. Med., 2015, 7:315ra190

[101] Zhao Y, Xu J. Synovial fluid-derived exosomal lncRNA PCGEM1 as biomarker for the different stages of osteoarthritis. Int. Orthop., 2018, 42:2865-2872

[102] Anderson HC. Matrix vesicles and calcification. Curr. Rheumatol. Rep., 2003, 5:222-226

[103] Jubeck B et al. Promotion of articular cartilage matrix vesicle mineralization by type I collagen. Arthritis Rheumatism., 2008, 58:2809-2817

[104] Shapiro IM, Landis WJ, Risbud MV. Matrix vesicles: are they anchored exosomes? Bone, 2015, 79:29-36

[105] Mitton E, Gohr CM, McNally MT, Rosenthal AK. Articular cartilage vesicles contain RNA. Biochem. Biophys. Res. Commun., 2009, 388:533-538

[106] Zheng L et al. Primary chondrocyte exosomes mediate osteoarthritis progression by regulating mitochondrion and immune reactivity. Nanomed. (Lond.)., 2019, 14:3193-3212

[107] Ni Z et al. The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1beta production of macrophages and aggravated synovitis in osteoarthritis. Cell Death Dis., 2019, 10:522

[108] Chen Y, Xue K, Zhang X, Zheng Z, Liu K. Exosomes derived from mature chondrocytes facilitate subcutaneous stable ectopic chondrogenesis of cartilage progenitor cells. Stem Cell Res. Ther., 2018, 9:318

[109] Mao G et al. Exosomal miR-95-5p regulates chondrogenesis and cartilage degradation via histone deacetylase 2/8. J. Cell. Mol. Med., 2018, 22:5354-5366.

[110] Song, J., Kang, Y., Chun, C. H. & Jin, E. J. Selective loading of exosomal HULC and miR-372 is responsible for chondrocyte death during OA pathogenesis. Anim. Cells Syst. 21, 397–403 (2017).

[111] Li Z et al. Chondrocytes-derived exosomal miR-8485 regulated the Wnt/beta-catenin pathways to promote chondrogenic differentiation of BMSCs. Biochem. Biophys. Res. Commun., 2020, 523:506-513

[112] Baker K et al. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann. Rheum. Dis., 2010, 69:1779-1783

[113] Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis., 2005, 64:1263-1267

[114] Hill CL et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann. Rheum. Dis., 2007, 66:1599-1603

[115] de Lange-Brokaar BJ et al. Association of pain in knee osteoarthritis with distinct patterns of synovitis. Arthritis Rheumatol., 2015, 67:733-740

[116] Robinson WH et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol., 2016, 12:580-592

[117] Krenn V et al. Grading of chronic synovitis–a histopathological grading system for molecular and diagnostic pathology. Pathol. Res. Pract., 2002, 198:317-325

[118] Wojdasiewicz P, Poniatowski LA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm., 2014, 2014:561459

[119] Bondeson J et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum., 2010, 62:647-657

[120] Pérez-Garcia S et al. Wnt and RUNX2 mediate cartilage breakdown by osteoarthritis synovial fibroblast-derived ADAMTS-7 and -12. J. Cell. Mol. Med., 2019, 23:3974-3983

[121] Kato T et al. Exosomes from IL-1beta stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res. Ther., 2014, 16:R163

[122] Tao SC et al. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics, 2017, 7:180-195

[123] Tsuno H et al. Effects of methotrexate and salazosulfapyridine on protein profiles of exosomes derived from a human synovial sarcoma cell line of SW982. Proteomics Clin. Appl., 2016, 10:164-171

[124] Castañeda S, Roman-Blas JA, Largo R, Herrero-Beaumont G. Subchondral bone as a key target for osteoarthritis treatment. Biochem. Pharmacol., 2012, 83:315-323

[125] Stewart HL, Kawcak CE. The importance of subchondral bone in the pathophysiology of osteoarthritis. Front. Vet. Sci., 2018, 5:178

[126] Maas O, Joseph GB, Sommer G, Wild D, Kretzschmar M. Association between cartilage degeneration and subchondral bone remodeling in patients with knee osteoarthritis comparing MRI and (99m)Tc-DPD-SPECT/CT. Osteoarthr. Cartil., 2015, 23:1713-1720

[127] Barr AJ et al. A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis. Arthritis Res. Ther., 2015, 17:228

[128] Cui Z et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-beta activity and H-type vessel formation in subchondral bone. Ann. Rheum. Dis., 2016, 75:1714-1721

[129] Zhu S et al. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J. Clin. Invest., 2019, 129:1076-1093

[130] Chen Y et al. Attenuation of subchondral bone abnormal changes in osteoarthritis by inhibition of SDF-1 signaling. Osteoarthr. Cartil., 2017, 25:986-994

[131] Xu T et al. Tenocyte-derived exosomes induce the tenogenic differentiation of mesenchymal stem cells through TGF-beta. Cytotechnology, 2019, 71:57-65

[132] Zhu QJ, Zhu M, Xu XX, Meng XM, Wu YG. Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-beta1/Smad3 pathway in vivo and in vitro. FASEB J., 2019, 33:9279-9290

[133] Yao Y, Chen R, Wang G, Zhang Y, Liu F. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-beta1/Smad pathway and promote repair of damaged endometrium. Stem Cell Res. Ther., 2019, 10:225

[134] Cai Z et al. Immunosuppressive exosomes from TGF-beta1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Res., 2012, 22:607-610

[135] Liu B et al. [Differential expression of exosomal miRNAs in osteoblasts in osteoarthritis]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2018, 43:1294-1300

[136] Gandhi R et al. Microarray analysis of the infrapatellar fat pad in knee osteoarthritis: relationship with joint inflammation. J. Rheumatol., 2011, 38:1966-1972

[137] Ioan-Facsinay A, Kloppenburg M. An emerging player in knee osteoarthritis: the infrapatellar fat pad. Arthritis Res. Ther., 2013, 15:225

[138] Cai J et al. Association between infrapatellar fat pad volume and knee structural changes in patients with knee osteoarthritis. J. Rheumatol., 2015, 42:1878-1884

[139] Ballegaard C et al. Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients with osteoarthritis: a cross-sectional study. Osteoarthr. Cartil., 2014, 22:933-940

[140] Belluzzi E et al. Contribution of infrapatellar fat pad and synovial membrane to knee osteoarthritis pain. BioMed. Res. Int., 2019, 2019:6390182

[141] Distel E et al. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum., 2009, 60:3374-3377

[142] Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee, 2012, 19:902-907

[143] Toghraie FS et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit. Knee, 2011, 18:71-75

[144] Buckley CT et al. Functional properties of cartilaginous tissues engineered from infrapatellar fat pad-derived mesenchymal stem cells. J. Biomech., 2010, 43:920-926

[145] Buckley CT, Vinardell T, Kelly DJ. Oxygen tension differentially regulates the functional properties of cartilaginous tissues engineered from infrapatellar fat pad derived MSCs and articular chondrocytes. Osteoarthr. Cartil., 2010, 18:1345-1354

[146] Wu J et al. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials, 2019, 206:87-100

[147] Ibrahim M, Kartus JT, Steigen SE, Olsen R, Meknas K. More tendon degeneration in patients with shoulder osteoarthritis. Knee Surg. Sports Traumatol. Arthrosc., 2019, 27:267-275

[148] Plachel F et al. Repair failure increases the risk of developing secondary glenohumeral osteoarthritis: A long-term follow-up after open repair of large subscapularis tendon tears. Orthop. Traumatol. Surg. Res., 2019, 105:1529-1533

[149] Meknas K et al. Could tendinosis be involved in osteoarthritis? Scand. J. Med. Sci. Sports, 2012, 22:627-634

[150] Wang Y et al. Exosomes from tendon stem cells promote injury tendon healing through balancing synthesis and degradation of the tendon extracellular matrix. J. Cell. Mol. Med., 2019, 23:5475-5485

[151] Schulze-Tanzil G. Intraarticular ligament degeneration is interrelated with cartilage and bone destruction in osteoarthritis. Cells. 8, 990 (2019).

[152] Hill CL et al. Cruciate ligament integrity in osteoarthritis of the knee. Arthritis Rheum., 2005, 52:794-799

[153] Johnson VL et al. Loss of anterior cruciate ligament integrity and the development of radiographic knee osteoarthritis: a sub-study of the osteoarthritis initiative. Osteoarthr. Cartil., 2015, 23:882-887

[154] Davis JE et al. Accelerated knee osteoarthritis is associated with pre-radiographic degeneration of the extensor mechanism and cruciate ligaments: data from the Osteoarthritis Initiative. BMC Musculoskelet. Disord., 2019, 20

[155] Zhao LR, Mao JQ, Zhao BJ, Chen J. [Isolation and biological characteristics of exosomes derived from periodontal ligament stem cells]. Shanghai Kou Qiang Yi Xue, 2019, 28:343-348

[156] Wang Z et al. Cyclic stretch force induces periodontal ligament cells to secrete exosomes that suppress IL-1beta production through the inhibition of the NF-kappaB signaling pathway in macrophages. Front. Immunol., 2019, 10:1310

[157] Zhao M et al. Periodontal ligament fibroblasts regulate osteoblasts by exosome secretion induced by inflammatory stimuli. Arch. Oral. Biol., 2019, 105:27-34

[158] Kong L, Zheng LZ, Qin L, Ho KKW. Role of mesenchymal stem cells in osteoarthritis treatment. J. Orthop. Translation., 2017, 9:89-103

[159] Lee WY, Wang B. Cartilage repair by mesenchymal stem cells: Clinical trial update and perspectives. J. Orthop. Translation., 2017, 9:76-88

[160] De Bari C, Roelofs AJ. Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis. Curr. Opin. Pharmacol., 2018, 40:74-80

[161] Di Matteo B et al. Minimally manipulated mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review of clinical evidence. Stem Cells Int., 2019, 2019:1735242

[162] Wang W, Cao W. Treatment of osteoarthritis with mesenchymal stem cells. Sci. China Life Sci., 2014, 57:586-595

[163] Jo CH et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am. J. Sports Med., 2017, 45:2774-2783

[164] Kim S. H., et al. Intra-articular injection of culture-expanded mesenchymal stem cells without adjuvant surgery in knee osteoarthritis: a systematic review and meta-analysis. Am. J. Sports Med. 363546519892278 (2019).

[165] Garay-Mendoza D et al. The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis. Int. J. Rheum. Dis., 2018, 21:140-147

[166] Jo CH et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells, 2014, 32:1254-1266

[167] Yokota N et al. Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am. J. Sports Med., 2019, 47:2577-2583

[168] Shin YS, Yoon JR, Kim HS, Lee SH. Intra-articular injection of bone marrow-derived mesenchymal stem cells leading to better clinical outcomes without difference in MRI outcomes from baseline in patients with knee osteoarthritis. Knee Surg. Relat. Res., 2018, 30:206-214

[169] Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev., 2009, 20:419-427

[170] Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells, 2017, 35:851-858

[171] Xu Y et al. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2. J. Cell. Physiol., 2019, 234:21380-21394

[172] Xie C, Du LY, Guo F, Li X, Cheng B. Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration. Mol. Cell. Biochem., 2019, 458:11-26

[173] He J. G., Xie Q. L., Li B. B., Zhou L., Yan D. Exosomes derived from IDO1-overexpressing rat bone marrow mesenchymal stem cells promote immunotolerance of cardiac allografts. Cell Transplant. 27, 1657–1683 (2018).

[174] Zhao C et al. Exosomes derived from bone marrow mesenchymal stem cells inhibit complement activation in rats with spinal cord injury. Drug Des. Dev. Ther., 2019, 13:3693-3704

[175] Rong X et al. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/beta-catenin pathway. Stem Cell Res. Ther., 2019, 10:98

[176] Ding J, Wang X, Chen B, Zhang J, Xu J. Exosomes derived from human bone marrow mesenchymal stem cells stimulated by deferoxamine accelerate cutaneous wound healing by promoting angiogenesis. BioMed. Res. Int., 2019, 2019:9742765

[177] Xiong L., et al. Exosomes from bone marrow mesenchymal stem cells can alleviate early brain injury after subarachnoid hemorrhage through miRNA129-5p-HMGB1 pathway. Stem Cells Dev. 29, 212–221 (2020).

[178] Zhu G et al. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p. J. Cell. Physiol., 2019, 234:23736-23749

[179] Zhao L et al. Exosomes derived from bone marrow mesenchymal stem cells overexpressing microRNA-25 protect spinal cords against transient ischemia. J. Thorac. Cardiovasc. Surg., 2019, 157:508-517

[180] Asghar S, Litherland GJ, Lockhart JC, Goodyear CS, Crilly A. Exosomes in intercellular communication and implications for osteoarthritis. Rheumatology, 2020, 59:57-68

[181] Mianehsaz E et al. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res. Ther., 2019, 10:340

[182] Cosenza S, Ruiz M, Toupet K, Jorgensen C, Noel D. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci. Rep., 2017, 7

[183] Qi H et al. Exosomes derived from mesenchymal stem cells inhibit mitochondrial dysfunction-induced apoptosis of chondrocytes via p38, ERK, and Akt pathways. Vitr. Cell. Develop. Biol. Anim., 2019, 55:203-210

[184] Chen P et al. Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration. Theranostics, 2019, 9:2439-2459

[185] Li J et al. BMSCs-derived exosomes ameliorate pain via abrogation of aberrant nerve invasion in subchondral bone in lumbar facet joint osteoarthritis. J. Orthop. Res., 2019, 38:670-679

[186] Jin Z, Ren J, Qi S. Human bone mesenchymal stem cells-derived exosomes overexpressing microRNA-26a-5p alleviate osteoarthritis via down-regulation of PTGS2. Int. Immunopharmacol., 2020, 78:105946

[187] Ma J et al. Exosomes derived from akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D. Stem Cells Transl. Med., 2017, 6:51-59

[188] Shelton MN, Huang MB, Ali SA, Powell MD, Bond VC. Secretion modification region-derived peptide disrupts HIV-1 Nef’s interaction with mortalin and blocks virus and Nef exosome release. J. Virol., 2012, 86:406-419

[189] Liu C, Su C. Design strategies and application progress of therapeutic exosomes. Theranostics, 2019, 9:1015-1028

[190] Mao G et al. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A. Stem Cell Res. Ther., 2018, 9:247

[191] Liu C et al. Kartogenin enhances the therapeutic effect of bone marrow mesenchymal stem cells derived exosomes in cartilage repair. Nanomed. (Lond.)., 2020, 15:273-288

[192] Kurth T et al. Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthr. Cartil., 2007, 15:1178-1189

[193] Shirasawa S et al. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J. Cell. Biochem., 2006, 97:84-97

[194] Miyamoto C, Matsumoto T, Sakimura K, Shindo H. Osteogenic protein-1 with transforming growth factor-beta1: potent inducer of chondrogenesis of synovial mesenchymal stem cells in vitro. J. Orthop. Sci., 2007, 12:555-561

[195] Koizumi K et al. Synovial mesenchymal stem cells from osteo- or rheumatoid arthritis joints exhibit good potential for cartilage repair using a scaffold-free tissue engineering approach. Osteoarthr. Cartil., 2016, 24:1413-1422

[196] Enomoto T et al. Timing of intra-articular injection of synovial mesenchymal stem cells affects cartilage restoration in a partial thickness cartilage defect model in rats. Cartilage, 2020, 11:122-129

[197] Mak J et al. Intra-articular injection of synovial mesenchymal stem cells improves cartilage repair in a mouse injury model. Sci. Rep., 2016, 6

[198] Kondo S et al. Transplantation of aggregates of autologous synovial mesenchymal stem cells for treatment of cartilage defects in the femoral condyle and the femoral groove in microminipigs. Am. J. Sports Med., 2019, 47:2338-2347

[199] Ozeki N et al. Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats. Osteoarthr. Cartil., 2016, 24:1061-1070

[200] Zhu Y et al. Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Res. Ther., 2017, 8:64

[201] Guo SC et al. Exosomes from human synovial-derived mesenchymal stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head in the rat. Int. J. Biol. Sci., 2016, 12:1262-1272

[202] Kim YS, Koh YG. Comparative matched-pair analysis of open-wedge high tibial osteotomy with versus without an injection of adipose-derived mesenchymal stem cells for varus knee osteoarthritis: clinical and second-look arthroscopic results. Am. J. Sports Med., 2018, 46:2669-2677

[203] Manferdini C et al. Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum., 2013, 65:1271-1281

[204] Skalska U, Kontny E. Adipose-derived mesenchymal stem cells from infrapatellar fat pad of patients with rheumatoid arthritis and osteoarthritis have comparable immunomodulatory properties. Autoimmunity, 2016, 49:124-131

[205] Damia E et al. Adipose-derived mesenchymal stem cells: are they a good therapeutic strategy for osteoarthritis? Int. J. Mol. Sci., 2018, 19:1926

[206] Maumus M et al. Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis. Stem Cell Res., 2013, 11:834-844

[207] Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl. Med., 2019, 8:504-511

[208] Tofino-Vian M, Guillen MI, Perez Del Caz MD, Castejon MA, Alcaraz MJ. Extracellular vesicles from adipose-derived mesenchymal stem cells downregulate senescence features in osteoarthritic osteoblasts. Oxid. Med. Cell. Longev., 2017, 2017:7197598

[209] Tofino-Vian M, Guillen MI, Perez Del Caz MD, Silvestre A, Alcaraz MJ. Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell. Physiol. Biochem., 2018, 47:11-25

[210] Woo CH et al. Small extracellular vesicles from human adipose-derived stem cells attenuate cartilage degeneration. J. Extracell. Vesicles., 2020, 9:1735249

[211] Zhao C et al. Exosomes from adiposederived stem cells promote chondrogenesis and suppress inflammation by upregulating miR145 and miR221. Mol. Med. Rep., 2020, 21:1881-1889

[212] Ma Q, Liao J, Cai X. Different sources of stem cells and their application in cartilage tissue engineering. Curr. Stem Cell Res. Ther., 2018, 13:568-575

[213] Oldershaw RA. Cell sources for the regeneration of articular cartilage: the past, the horizon and the future. Int. J. Exp. Pathol., 2012, 93:389-400

[214] Hwang NS, Elisseeff J. Application of stem cells for articular cartilage regeneration. J. Knee Surg., 2009, 22:60-71

[215] Mamidi MK, Das AK, Zakaria Z, Bhonde R. Mesenchymal stromal cells for cartilage repair in osteoarthritis. Osteoarthr. Cartil., 2016, 24:1307-1316

[216] Gibson JD et al. Regeneration of articular cartilage by human ESC-derived mesenchymal progenitors treated sequentially with BMP-2 and Wnt5a. Stem Cells Transl. Med., 2017, 6:40-50

[217] Zhang S et al. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthr. Cartil., 2016, 24:2135-2140

[218] Zhang S et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials, 2018, 156:16-27

[219] Wang Y et al. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res. Ther., 2017, 8:189

[220] Zhang S et al. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials, 2019, 200:35-47

[221] Wang R, Xu B, Xu H. TGF-beta1 promoted chondrocyte proliferation by regulating Sp1 through MSC-exosomes derived miR-135b. Cell Cycle, 2018, 17:2756-2765

[222] Zavatti M, Beretti F, Casciaro F, Bertucci E, Maraldi T. Comparison of the therapeutic effect of amniotic fluid stem cells and their exosomes on monoiodoacetate-induced animal model of osteoarthritis. BioFactors, 2019, 46:106-117

[223] Yan L, Wu X. Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity. Cell Biol. Toxicol., 2019, 36:165-178

[224] Luo P, Jiang C, Ji P, Wang M, Xu J. Exosomes of stem cells from human exfoliated deciduous teeth as an anti-inflammatory agent in temporomandibular joint chondrocytes via miR-100-5p/mTOR. Stem Cell Res. Ther., 2019, 10:216

[225] Tai YL, Chen KC, Hsieh JT, Shen TL. Exosomes in cancer development and clinical applications. Cancer Sci., 2018, 109:2364-2374

[226] Deng H et al. Lipid, protein, and microRNA composition within mesenchymal stem cell-derived exosomes. Cell. Reprogramming., 2018, 20:178-186

[227] Zhang ZG, Buller B, Chopp M. Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nat. Rev. Neurol., 2019, 15:193-203

[228] Ragni E et al. Identification of miRNA reference genes in extracellular vesicles from adipose derived mesenchymal stem cells for studying osteoarthritis. Int. J. Mol. Sci., 2019, 20:1108

[229] Carames B et al. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann. Rheum. Dis., 2012, 71:575-581

[230] Takayama K et al. Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res. Ther., 2014, 16:482

[231] Zhang Y et al. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann. Rheum. Dis., 2015, 74:1432-1440

[232] Dragomir M, Chen B, Calin GA. Exosomal lncRNAs as new players in cell-to-cell communication. Transl. Cancer Res., 2018, 7:S243-S252

[233] Liu T et al. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget, 2016, 7:85551-85563

[234] Isin M et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front. Genet., 2015, 6:168

[235] Conigliaro A et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol. Cancer, 2015, 14

[236] Lang HL et al. Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3. Eur. Rev. Med. Pharmacol. Sci., 2017, 21:959-972

[237] Zheng R et al. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol. Cancer, 2018, 17

[238] Patel NA et al. Long noncoding RNA MALAT1 in exosomes drives regenerative function and modulates inflammation-linked networks following traumatic brain injury. J. Neuroinflammation., 2018, 15

[239] Liu Y et al. Exosomal KLF3-AS1 from hMSCs promoted cartilage repair and chondrocyte proliferation in osteoarthritis. Biochem. J., 2018, 475:3629-3638

[240] Liu Y et al. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis. Cell Cycle, 2018, 17:2411-2422

[241] Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active Wnt proteins are secreted on exosomes. Nat. Cell Biol., 2012, 14:1036-1045

[242] Buschow SI, Liefhebber JM, Wubbolts R, Stoorvogel W. Exosomes contain ubiquitinated proteins. Blood Cells Mol. Dis., 2005, 35:398-403

[243] Thery C et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol., 1999, 147:599-610

[244] Yuan D et al. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials, 2017, 142:1-12

[245] Whiteside TL. Exosomes carrying immunoinhibitory proteins and their role in cancer. Clin. Exp. Immunol., 2017, 189:259-267

[246] Goetzl EJ et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease. FASEB J., 2016, 30:4141-4148

[247] Tsuno H et al. A proteomic analysis of serum-derived exosomes in rheumatoid arthritis. BMC Rheumatol., 2018, 2

[248] Kawakami K et al. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer. BMC Cancer, 2017, 17

[249] Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer, 2009, 10:42-46

[250] Lv LL et al. MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am. J. Physiol. Ren. Physiol., 2013, 305:F1220-F1227

[251] Song J et al. PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin. Exp. Med., 2015, 15:121-126

[252] van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthr. Cartil., 2010, 18:605-612

[253] Charni N, Juillet F, Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum., 2005, 52:1081-1090

[254] Garnero P, Charni N, Juillet F, Conrozier T, Vignon E. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann. Rheum. Dis., 2006, 65:1639-1644

[255] van der Lubbe N et al. The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism. Hypertension, 2012, 60:741-748

[256] Yazarlou F et al. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer. Cancer Manag. Res., 2018, 10:6357-6365

[257] Street JM, Koritzinsky EH, Glispie DM, Star RA, Yuen PS. Urine exosomes: an emerging trove of biomarkers. Adv. Clin. Chem., 2017, 78:103-122

[258] Rashed MH et al. Exosomes: from garbage bins to promising therapeutic targets. Int. J. Mol. Sci., 2017, 18:538

[259] Gernapudi R et al. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast Cancer Res. Treat., 2015, 150:685-695

[260] Hornick NI et al. AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. Sci. Signal., 2016, 9:ra88

[261] Chen P et al. Extraction and identification of synovial tissue-derived exosomes by different separation techniques. J. Orthop. Surg. Res., 2020, 15

[262] Kamerkar S et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature, 2017, 546:498-503

[263] Qi H et al. Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano., 2016, 10:3323-3333

[264] Tian T et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials, 2018, 150:137-149

[265] Gilligan K. E., Dwyer R. M. Engineering exosomes for cancer therapy. Int. J. Mol. Sci. 18, 1122 (2017).

[266] Liu X et al. Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration. Nanoscale, 2017, 9:4430-4438

[267] Wang C et al. Engineering bioactive self-healing antibacterial exosomes hydrogel for promoting chronic diabetic wound healing and complete skin regeneration. Theranostics, 2019, 9:65-76

[268] Shi Q et al. GMSC-derived exosomes combined with a chitosan/silk hydrogel sponge accelerates wound healing in a diabetic rat skin defect model. Front. Physiol., 2017, 8:904

[269] Han C et al. Human umbilical cord mesenchymal stem cell derived exosomes encapsulated in functional peptide hydrogels promote cardiac repair. Biomater. Sci., 2019, 7:2920-2933

[270] Liu X et al. Exosomes derived from platelet-rich plasma present a novel potential in alleviating knee osteoarthritis by promoting proliferation and inhibiting apoptosis of chondrocyte via Wnt/beta-catenin signaling pathway. J. Orthop. Surg. Res., 2019, 14